Publications and sources: Difference between revisions
Make the 2025 medico-pharmaceutical law book discoverable |
Add complete multilingual reference and language navigation |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Publications and sources|English]] · [[Publications and sources/uk|Українська]] · [[Publications and sources/es|Español]] · [[Publications and sources/fr|Français]] · [[Publications and sources/de|Deutsch]] · [[Publications and sources/pt|Português]]</div> | |||
= Publications and sources = | = Publications and sources = | ||
This is a starting catalogue, not an exhaustive bibliography. | This is a starting catalogue, not an exhaustive bibliography. | ||
| Line 27: | Line 28: | ||
* [[US copyright registration]]: the 2025 book and its documented registration, distinct from a patent. | * [[US copyright registration]]: the 2025 book and its documented registration, distinct from a patent. | ||
* [[Terms and concepts]]: a subject guide to explanatory entries. | * [[Terms and concepts]]: a subject guide to explanatory entries. | ||
== People behind the publications == | |||
[[Research network]] maps dated coauthor connections to the works above and additional primary records. Individual author pages retain identity keys and distinguish institutional roles from intellectual contributions. | |||
== Research before 2021 == | |||
* [[Research before 2021]]: publisher-grounded descriptions and historical context. | |||
* [[ORCID bibliography before 2021]]: 21 public work records with English topic descriptions and exact work links. | |||
The two guides distinguish original issue years, later online dates, translations and differing evidence levels. | |||
Latest revision as of 00:52, 12 November 2026
Publications and sources
This is a starting catalogue, not an exhaustive bibliography.
Published works
- The Concept of Medico-Pharmaceutical Law: Principles, Advantages and Risks of Integration (2025), DOI 10.53933/3qgntf55.
- Biologically active substances in hydrazide derivatives of succinic heterylamides (1989).
- Vision 2035 – Medico-Pharmaceutical Law for Human Security (2026).
- Recipra as a Proposed Successor to Ethics (2026).
Bibliographic and project records
- History and research foundations links early ORCID records and the selected book lineage.
- POAMPL and public activity links preprints and institutional activities.
- Vision 2035 Revision 2027, polished working review v0.35, 9 November 2026: a working manuscript, not automatically a published edition.
Publication platforms
Original editions, translations, revisions, preprints and final published articles should be listed separately. Individual source licences apply; this wiki does not relicense third-party works.
Expanded reading guides
- Pharmaceutical law in safe self-medication: editions, contents and the limits of older medicine-reference literature.
- Journal research map: article-linked conceptual themes across the journals.
- Evolving Authorship: contribution roles and intellectual attribution.
- US copyright registration: the 2025 book and its documented registration, distinct from a patent.
- Terms and concepts: a subject guide to explanatory entries.
People behind the publications
Research network maps dated coauthor connections to the works above and additional primary records. Individual author pages retain identity keys and distinguish institutional roles from intellectual contributions.
Research before 2021
- Research before 2021: publisher-grounded descriptions and historical context.
- ORCID bibliography before 2021: 21 public work records with English topic descriptions and exact work links.
The two guides distinguish original issue years, later online dates, translations and differing evidence levels.